The most common mechanism of PI3K pathway activation is through mutations or amplifications of PIK3CA, where p110α plays an important role in the tumorigenesis of BC though extra-nuclear ER signaling, and is often responsible for endocrine treatment resistance [36]. This evidence concerns the gene PIK3CA and breast cancer.